摘要
Conspectus For more than a century, synthetic organic electrochemistry has held out the promise of using electrons and holes─the universe’s cheapest and most tunable redox reagents─to orchestrate bond construction and functional-group interconversion with unparalleled precision and sustainability. Yet, for decades, its role in total synthesis remained peripheral, usually invoked when all else failed or as an alternative to reactions with a chemical counterpart. Why did a technique whose industrial pedigree includes multi-ton processes at BASF languish at the margins of academic complex molecule synthesis until the past ten years? The reasons are as familiar as they are frustrating: bespoke equipment, a steep learning curve, and the comforting (if often illusory) notion that “chemical reagents can do that, too.” Our laboratory’s entry into the field was pragmatically rather than philosophically driven. During the total synthesis of dixiamycin, exhaustive screening of chemical oxidants failed to forge the requisite N–N bond; constant-potential electrolysis succeeded cleanly. That single, necessity-driven success in 2014 marked the beginning of a deliberate campaign to move electrochemistry from workaround to strategic centerpiece. What followed was a convergence of two enabling developments: (1) the commercialization of standardized, user-friendly potentiostats that removed the engineering barrier, and (2) the invention of fundamentally novel reactivity─most notably, electrochemical radical cross-couplings─that unlocked intermolecular C–C bond formations between late-stage, densely functionalized fragments in manners hardly accessible using classic two-electron methods. In this Account, we illustrate how these advances have rippled across every major natural-product class and bond type. Strategic functionalizations such as decarboxylative borylations (jawsamycin) and site-selective C–H oxidations (valencene, sclareolide, mitrephorone) now deliver gram-scale intermediates with minimal concession steps. Electrochemical C–N and C–O constructions have powered protecting-group-sparing routes to teleocidins, dragocins, and bipolarolides. The real paradigm shift, however, lies in intermolecular radical cross-couplings. C(sp2)–C(sp3) unions have enabled modular, scalable entries to polyene cores (progesterone, celastrol, isosteviol, vitamin D analogues) and complex macrocycles (bipinnatin J, micitide 982), while doubly decarboxylative C(sp3)–C(sp3) couplings have delivered 15 natural products, including polyrhacitide A and PF1163A, both stemming from a single, inexpensive building block with ligand-controlled diastereoselectivity. Most strikingly, two sequential electrochemical couplings furnished over a gram of the intricate antibiotic nonthmicin, tolerating epoxides and free diols that would have derailed any conventional tactic. Electrochemistry has therefore ceased to be a niche curiosity and has become standard practice in our laboratory (64 syntheses to date)─and, increasingly, in the broader community. It offers an orthogonal retrosynthetic logic that maximizes convergence, minimizes redox fluctuations and protecting groups, and leverages inexpensive electricity rather than stoichiometric metals or pyrophoric reagents. The field now stands at an inflection point: practical paired electrolyses, direct reductive transformations, and mediator systems capable of engaging ever more complex substrates are within reach. For the synthetic chemist who has contemplated a stubborn redox problem or a chemoselectivity impasse, electrochemistry is no longer a last resort─it is an obvious tool to consider employing.